Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Allain

Showing results (471-480 of 497) with videos related to

Pageof 50
Sort By:
Blood|November 1, 1991
Prediction of hepatitis C virus infectivity in seropositive Australian blood donors by supplemental immunoassays and detection of viral RNAJ P Allain, P J Coghlan, K G Kenrick, et al.
Thrombosis and Haemostasis|December 23, 1981
HLA antigens and factor VIII antibody in classic hemophilia. European study group of factor VIII antibodyD Frommel, J P Allain, E Saint-Paul, et al.
Blood|March 1, 1991
Monitoring of specific antibodies to human immunodeficiency virus structural proteins: clinical significanceJ P Allain, Y Laurian, M H Einstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1997
Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patientsE Gamelin, A L Bouil, M Boisdron-Celle, et al.
Reviews of Infectious Diseases|July 1, 1990
The National Cancer Institute phase I study of 2',3'-dideoxyinosine administration in adults with AIDS or AIDS-related complex: analysis of activity and toxicity profilesR Yarchoan, H Mitsuya, J M Pluda, et al.
Science (New York, N.Y.)|July 28, 1989
In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosineR Yarchoan, H Mitsuya, R V Thomas, et al.
Blood|October 27, 1998
A multicenter prospective study on the risk of acquiring liver disease in anti-hepatitis C virus negative patients affected from homozygous beta-thalassemiaD Prati, A Zanella, E Farma, et al.
Lancet (London, England)|January 16, 1988
Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT)R Yarchoan, C F Perno, R V Thomas, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 28, 2012
Impaired decision-making and brain shrinkage in alcoholismA-P Le Berre, G Rauchs, R La Joie, et al.
Frontiers in Bioinformatics|May 30, 2023
Application of annotation-agnostic RNA sequencing data analysis tools for biomarker discovery in liquid biopsyGabriel Wajnberg, Eric P Allain, Jeremy W Roy, et al.
Pageof 50

Showing results (471-480 of 497) with videos related to

Sort By:
Pageof 50
Blood|November 1, 1991
Prediction of hepatitis C virus infectivity in seropositive Australian blood donors by supplemental immunoassays and detection of viral RNAJ P Allain, P J Coghlan, K G Kenrick, et al.
Thrombosis and Haemostasis|December 23, 1981
HLA antigens and factor VIII antibody in classic hemophilia. European study group of factor VIII antibodyD Frommel, J P Allain, E Saint-Paul, et al.
Blood|March 1, 1991
Monitoring of specific antibodies to human immunodeficiency virus structural proteins: clinical significanceJ P Allain, Y Laurian, M H Einstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1997
Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patientsE Gamelin, A L Bouil, M Boisdron-Celle, et al.
Reviews of Infectious Diseases|July 1, 1990
The National Cancer Institute phase I study of 2',3'-dideoxyinosine administration in adults with AIDS or AIDS-related complex: analysis of activity and toxicity profilesR Yarchoan, H Mitsuya, J M Pluda, et al.
Science (New York, N.Y.)|July 28, 1989
In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosineR Yarchoan, H Mitsuya, R V Thomas, et al.
Blood|October 27, 1998
A multicenter prospective study on the risk of acquiring liver disease in anti-hepatitis C virus negative patients affected from homozygous beta-thalassemiaD Prati, A Zanella, E Farma, et al.
Lancet (London, England)|January 16, 1988
Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT)R Yarchoan, C F Perno, R V Thomas, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 28, 2012
Impaired decision-making and brain shrinkage in alcoholismA-P Le Berre, G Rauchs, R La Joie, et al.
Frontiers in Bioinformatics|May 30, 2023
Application of annotation-agnostic RNA sequencing data analysis tools for biomarker discovery in liquid biopsyGabriel Wajnberg, Eric P Allain, Jeremy W Roy, et al.
Pageof 50